GMP News - APIs and Excipients

01.08.18

Cooperation of international authorities for inspecting API manufacturers

The aim of the International API Inspection Programme is the cooperation of authorities in monitoring and controlling API manufacturers. Read here, by which measures an optimised bundling and efficiency enhancement of the regulatory supervision of API facilities via GMP inspections are to be reached.

more

26.07.18

Missing glycerin test for diethylene glycol leads to FDA warning letter

Glycerin is often used as an excipient in solid and semisolid dosage forms. For companies supervised by the FDA, comprehensive testing of the incoming excipient is mandatory. Otherwise, they risk receiving a warning letter, like an Irish pharmaceutical company recently did. The deficiencies the FDA inspectors found in the areas of quality control and quality assurance are described here.

more

23.05.18

GMP for APIs practically applied - the revised APIC "How to do" guideline

The "How to do" document is one of APIC's many Best Practices Documents and has been upgraded to the current state of the art. Read here which practical recommendations in the implementation of GMP for APIs are included in the most recent version of the How-to-do document.

more

09.05.18

Regulatory classification of API co-crystals in the US Approval Procedure

To use an active substance in a form which ensures optimum processing is important for an efficient production process; but what does that mean for approval procedures? Read here how the FDA classifies active pharmaceutical ingredients in co-crystalline form during an approval procedure.

more

02.05.18

Warning Letter due to unsuitable Production Equipment and insufficient Process Validation

The minimum requirements for a robust production process are suitable facilities and equipment. Read here about what FDA inspectors identified as root causes for impurities and quality variations in the production of active pharmaceutical ingredients (APIs).

more

02.05.18

Revised Ph. Eur. Monographs on Excipients due to ICH Q3D

Several Ph. Eur. Monographs on excipients used in semi-solid formulations have been proposed for comment. Read more about the monographs on oils, fats, waxes, emulsifiers.

more

18.04.18

Auditing Starting Materials - new APIC Guideline defines Standards

The use of starting materials in the production process for active pharmaceutical ingredients marks the starting point for GMP. But how can the quality of starting materials be ensured? Find out about what standards for auditing starting materials APIC has defined in their new guideline here.

more

18.04.18

Warning Letter due to falsified Data and poor Maintenance

The attempt to conceal hygiene deficiencies with inaccurate lab data resulted in a virtually inevitable Warning Letter after an FDA inspection. Read here, which violations of fundamental GMP rules for maintenance and cleaning of production equipment at an API facility were criticised by the inspectors.

more

21.02.18

Disregard of general GMP Principles at Indian API Facility

During the inspection of an Indian active pharmaceutical ingredient manufacturer, European GMP inspectors were met with severe deficiencies. Read here, which violations of GMP principles for production, laboratory and handling of reference samples led to a Non-Compliance Report. 

more

20.02.18

FDA revises Guideline on HIV and HCV Testing for the Assessment of Blood Donors

With an update of their guideline on NAT testing of blood and plasma donations for HIV-1 and HCV, the FDA takes account of the developments regarding methods and related regulations.

more

31.01.18

WHO publishes Guideline on Worker Safety relating to Nanomaterials

Relating to the increasing use of nanomaterials in manufacturing and the possible following risks for manufacturing staff the WHO issued a new guideline document entitled "WHO guidelines on protecting workers from potential risks of manufactured nanomaterials" .

more

24.01.18

Five new Warning Letters - Four Batch Record Review Citations

Data integrity is for sure still a hot topic in inspections. But it seems inspectors are getting more back to the roots: document and batch record design and review.

more

24.01.18

Bizarre Warning Letter to Chinese Drug Manufacturer

Over the past months, the ECA reported about the growing number of Warning Letters issued to Asian companies. A recent FDA Warning Letter resulted in a ban on imports for a Chinese manufacturer of pharmaceutical products.

more

29.11.17

Warning Letter: fundamental GMP Deficiencies in API Production

Fundamental violations of GMP basics in the area of API production found in an official inspection usually lead to unpleasant consequences or, in case of FDA inspections, to a Warning Letter. Read more on which issues concerning in-process controls, documentation and OOS results are intolerable.

more

13.09.17

API starting materials - New Q&A document for ICH Q11

The recently published ICH question/answer document on starting materials specifies the regulations of the guideline ICH Q11. Read more about what is important in terms of the selection of starting materials and their justification and what data needs to be supplied in the marketing authorisation dossier.

more

GMP Newsletter

Sign up for the free of charge newsletters.

Sign up now!

GMP Conferences by Topics